Hana Dobrovolny

Associate Professor of Biophysics




I received a B.Sc. in Physics and Mathematics from the University of Winnipeg, followed by an M.Sc in Physics from Bryn Mawr College and a Ph.D in Physics from Duke University. I started research in modeling of infectious diseases as a postdoc at Ryerson University and have continued this research as faculty at Texas Christian University.

Preferred Pronouns


Personal Academic Website

Research/Topics of Interest

Agent-based models
Between-host modeling
Compartmental models
Intra-host modeling
Outbreak science
Science communication
Spatial transmission patterns
computer simulation
respiratory syncytial virus

Pathogens/Diseases of Main Interest/Expertise

Pandemic influenza
Respiratory diseases
Season influenza

Countries of Work/Collaboration

United States



Amidei A, Dobrovolny HM. (2022). Estimation of virus-mediated cell fusion rate of SARS-CoV-2. Virology, (575)

Pinky L, Dobrovolny HM. (2022). Epidemiological Consequences of Viral Interference: A Mathematical Modeling Study of Two Interacting Viruses. Frontiers in microbiology, (13)

Khan S, Dobrovolny HM. (2021). A study of the effects of age on the dynamics of RSV in animal models. Virus research, (304)

Rodriguez T, Dobrovolny HM. (2021). Quantifying the effect of trypsin and elastase on in vitro SARS-CoV infections. Virus research, (299)

Jessie B, Dobrovolny HM. (2021). The role of syncytia during viral infections. Journal of theoretical biology, (525)

Frieler M, Pho C, Lee BH, Dobrovolny H, Akkaraju GR, Naumov AV. (2021). Effects of Doxorubicin Delivery by Nitrogen-Doped Graphene Quantum Dots on Cancer Cell Growth: Experimental Study and Mathematical Modeling. Nanomaterials (Basel, Switzerland), 11(1)

Pho C, Frieler M, Akkaraju GR, Naumov AV, Dobrovolny HM. (2021). Using mathematical modeling to estimate time-independent cancer chemotherapy efficacy parameters. In silico pharmacology, 10(1)

Rodriguez T, Dobrovolny HM. (2021). Estimation of viral kinetics model parameters in young and aged SARS-CoV-2 infected macaques. Royal Society open science, 8(11)

Schmid H, Dobrovolny HM. (2020). An approximate solution of the interferon-dependent viral kinetics model of influenza. Journal of theoretical biology, (498)

Pinky L, Dobrovolny HM. (2020). SARS-CoV-2 coinfections: Could influenza and the common cold be beneficial?. Journal of medical virology, 92(11)

Murphy H, McCarthy G, Dobrovolny HM. (2020). Understanding the effect of measurement time on drug characterization. PloS one, 15(5)

Dobrovolny HM. (2020). Modeling the role of asymptomatics in infection spread with application to SARS-CoV-2. PloS one, 15(8)

Rowell CER, Dobrovolny HM. (2020). Energy Requirements for Loss of Viral Infectivity. Food and environmental virology, 12(4)

Dobrovolny HM. (2020). Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2. Virology, (550)

González-Parra G, Dobrovolny HM. (2019). The rate of viral transfer between upper and lower respiratory tracts determines RSV illness duration. Journal of mathematical biology, 79(2)

Pinky L, Gonzalez-Parra G, Dobrovolny HM. (2019). Effect of stochasticity on coinfection dynamics of respiratory viruses. BMC bioinformatics, 20(1)

Pinky L, González-Parra G, Dobrovolny HM. (2019). Superinfection and cell regeneration can lead to chronic viral coinfections. Journal of theoretical biology, (466)

González-Parra G, Dobrovolny HM. (2018). Modeling of fusion inhibitor treatment of RSV in African green monkeys. Journal of theoretical biology, (456)

González-Parra G, Dobrovolny HM. (2018). A quantitative assessment of dynamical differences of RSV infections in vitro and in vivo. Virology, (523)

Melville K, Rodriguez T, Dobrovolny HM. (2018). Investigating Different Mechanisms of Action in Combination Therapy for Influenza. Frontiers in pharmacology, (9)

Deecke L, Dobrovolny HM. (2018). Intermittent treatment of severe influenza. Journal of theoretical biology, (442)

Gonzàlez-Parra G, De Ridder F, Huntjens D, Roymans D, Ispas G, Dobrovolny HM. (2018). A comparison of RSV and influenza in vitro kinetic parameters reveals differences in infecting time. PloS one, 13(2)

Dobrovolny HM, Beauchemin CAA. (2017). Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms. PloS one, 12(7)

Pinky L, Dobrovolny HM. (2017). The impact of cell regeneration on the dynamics of viral coinfection. Chaos (Woodbury, N.Y.), 27(6)

If you’d like to update your profile, please email modifications to

This site is registered on as a development site.